 |
| Diana Scott |
Finn Partners has added Diana Scott, who most recently was senior VP at Porter Novelli in her more than 20-year healthcare PR career, as partner in its health unit.
She has extensive experience in oncology, cardiometabolic disease categories and has promoted pharmaceutical portfolios, product launches, global data communications campaigns and handled regulatory support.
"Content drives communications across all medium and Finn has an obligation to clients championing the cancer, cardiovascular, mental health and rare disease categories to be a strong partner ensuring our efforts lead to life-improving action," Gil Bashe, managing partner of Finn's global health practice, told O'Dwyer's. "Hiring Diana Scott, with her clinical expertise and proven ability to mobilize communities, responds to that client environment.”
Scott, who also held top jobs in the healthcare units of Weber Shandwick and Ruder Finn, reports to Kristie Kuhl, managing partner of Finn Partners' New York and Chicago health teams and head of the US pharma group.
Finn Partners ranked No. 6 in O'Dwyer's 2018 healthcare rankings with fees of $21.2M.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
